There has been an increase in the antibiotic resistance in the past few years. There are many publications from various institutions in India showing high level of resistance to antibiotics.
Government of India has launched the ‘National Programme on Containment of Antimicrobial Resistance (AMR)’ under the 12th Five Year Plan under which a surveillance lab network of ten labs has been established to monitor trends of AMR in the country. The trends from AMR data gathered in the year 2015 from these tertiary care centres show high resistance to commonly used antibiotics for treatment of bacterial infections.
Through various studies conducted in various institutions in India, it is a known fact that over/ mis-use of antimicrobial drugs are responsible for rising antimicrobial resistance in human, animal and food sectors. Other factors are inadequate sanitation and infection control practices in health care settings and also in the community.
The Schedule H1 notification of the Government of India on Aug 30, 2013, as an amendment to the Drugs and Cosmetics Rules of 1945, came into force from Mar 1, 2014 to control the misuse of 24 antibiotics (falling under third and fourth generation) through over-the-counter (OTC) dispensing of antibiotics in India. The packaging of these drugs will have mandatory Schedule H1 warning printed on the label in a box with red border and the Rx symbol in red. They can be sold by pharmaceutical chemists only on production of a valid prescription. Government drug inspectors can conduct surprise checks on these registers.
The Minister of State (Health and Family Welfare), Smt Anupriya Patel stated this in a written reply in the Lok Sabha here today.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
